KEGG pathway analysis further identified the PI3K-Akt pathway, general cancer pathways, and other malignancy-specific pathways (e.g., melanoma, bladder cancer, breast cancer) as central to OSCC progression (31). The gene discussed is AKT1; the disease is urinary bladder carcinoma.